SOPHiA GENETICS Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	103.74	123.25	161.31	192.96	74.63	18.44
Short-Term Investments	0	0	17.31	72.36	22.72	0
Cash & Cash Equivalents	103.74	123.25	178.61	265.32	97.35	18.44
Cash Growth	-35.91%	-31.00%	-32.68%	172.56%	428.04%	-
Receivables	10.89	13.56	6.65	6.28	6.36	7.93
Inventory	6.02	6.48	5.16	5.73	3.38	3.61
Other Current Assets	4.49	4.76	5.84	5.53	2.6	3.79
Total Current Assets	125.13	148.05	196.26	282.86	109.69	33.76
Property, Plant & Equipment	21.3	23.1	21.4	15.96	5.54	6.45
Goodwill and Intangibles	26.29	27.19	19.96	15.67	13.28	10.24
Other Long-Term Assets	7.54	7.82	6.22	5.69	3.6	1.21
Total Long-Term Assets	55.13	58.11	47.58	37.32	22.42	17.9
Total Assets	180.26	206.16	243.84	320.17	132.12	51.66
Accounts Payable	6.25	5.39	6.18	6.74	5.91	5.4
Deferred Revenue	8.34	9.49	3.43	4.07	2.78	2.18
Current Debt	2.7	2.93	2.69	1.81	3.91	3.19
Other Current Liabilities	12.91	17.81	14.51	15.98	8.99	8.49
Total Current Liabilities	30.19	35.62	26.81	28.6	21.59	19.26
Long-Term Debt	14.74	15.67	14.05	11.25	3.34	5.27
Other Long-Term Liabilities	3.1	3.42	2.85	4.92	6.68	4.87
Total Long-Term Liabilities	17.83	19.09	16.9	16.17	10.02	10.15
Total Liabilities	48.03	54.71	43.71	44.77	31.61	29.4
Total Debt	17.44	18.6	16.74	13.06	7.25	8.46
Debt Growth	-1.69%	11.10%	28.21%	80.15%	-14.35%	-
Retained Earnings	-391.49	-377.78	-298.8	-211.35	-137.68	-98.34
Shareholders' Equity	132.23	151.44	200.13	275.4	100.51	22.25
Net Cash / Debt	86.29	104.65	161.87	252.26	90.1	9.97
Net Cash / Debt Growth	-40.12%	-35.35%	-35.83%	179.99%	803.58%	-
Working Capital	94.93	112.43	169.45	254.25	88.11	14.5
Book Value Per Share	2.03	2.33	3.12	4.31	1.59	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).